Is a 0.2% chance of death from breast cancer worth a bilateral prophylactic mastectomy?

Article

That's the choice women with one or more breast cancer risk factors have to make, according to the results of a recent retrospective case-cohort study of women aged 18 to 80.

That's the choice women with one or more breast cancer risk factors have to make, according to the results of a recent retrospective case-cohort study of women aged 18 to 80.

Researchers studied 276 women who received bilateral prophylactic mastectomy and a random sample of 196 women representing an underlying cohort of 666,800 women with elevated breast cancer risk but no mastectomy. Breast cancer risk factors consisted of a family history of the disease, a history of atypical hyperplasia, and one or more breast biopsies with benign findings.

Breast cancer developed in one woman (0.4%) after bilateral breast removal and in 26,800 women (4.0%) who did not opt for the prophylactic procedure, making the hazard ratio for breast cancer occurrence after bilateral mastectomy 0.005 (95% CI, 0.001–0.044). None of the women who elected to have the procedure died of breast cancer, while 0.2% of those who did not have a mastectomy died of the disease.

Recent Videos
Supreme Court upholds mifepristone access: Implications for women's health | Image Credit: linkedin.com
The significance of the Supreme Court upholding mifepristone access | Image Credit: unchealth.org
One year out: Fezolinetant displays patient satisfaction for managing hot flashes | Image Credit: sutterhealth.org
Addressing maternal health inequities: Insights from CDC's Wanda Barfield | Image Credit: cdc.gov
Addressing racial and ethnic disparities in brachial plexus birth Injury | Image Credit: shrinerschildrens.org
Innovations in prenatal care: Insights from ACOG 2024 | Image Credit:  uofmhealth.org.
Unlocking therapeutic strategies for menopausal cognitive decline | Image Credit: uclahealth.org.
Navigating menopause care: Expert insights from ACOG 2024 | Image Credit: mayo.edu.
© 2024 MJH Life Sciences

All rights reserved.